Austin Gold Venture Bioleaching: Project Summary

"Bioleach testing and piloting was conducted on refractory gold sulphide concentrate from Austin Gold Venture in Nevada during 1988. The objective of the test programme was to determine the technical and commercial viability of bioleaching as a concentrate pretreatment step prior to gold extraction by cyanidation. Baseline CIL cyanidation typically resulted in < 20% gold extraction from the Austin concentrate. Bioleaching enhanced gold extraction up to 95% using conventional CIL techniques. This paper summarizes the bioleach test programme and results, including pilot plant studies onsite, and describes the commercial design details for a possible retrofit of the Austin flotation tailings leach circuit to accommodate 20 tpd and 40 tpd capacity concentrate bioleach facilities.INTRODUCTIONBioleach testing on a refractory carbonaceous sulphide concentrate from Austin Gold Venture (AGV), was initiated in late 1987 as part of an ongoing programme at Austin to investigate alternatives to concentrate smelting. Preliminary batch biooxidation tests at Coastech indicated that over 90% gold extraction by carbon-in-leach (CIL) cyanidation of the bioleach residue could be achieved, compared with less than 20% gold extraction on untreated concentrate by similar CIL processing.Subsequently, a more rigorous laboratory study was undertaken at Coastech to establish continuous biooxidation operating criteria on a bench scale. The objective of continuous testing in the laboratory was to provide confirmation of enhanced CIL response based on continuous bioleach products and to determine key process operating and design parameters for pilot testing. The success of the laboratory test program led to the installation of a mobile pilot plant at Austin Gold Venture. The plant was operated by Coastech and AGV during 1988 to provide scaleup data and design criteria for commercial design and feasibility analysis. Based on pilot plant operating data, a detailed commercial bioleach plant was designed as a possible retrofit to the existing 1000 tpd CIL plant. Capital and operating costs were estimated to provide a commercial feasibility study of bioleaching as an oxidative pretreatment for Austin refractory concentrate."